{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T15:44:01Z","timestamp":1787499841996,"version":"build-2736575974"},"reference-count":67,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2022,4,19]],"date-time":"2022-04-19T00:00:00Z","timestamp":1650326400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,4,19]],"date-time":"2022-04-19T00:00:00Z","timestamp":1650326400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100012166","name":"MOST|National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2021YFE0202800"],"award-info":[{"award-number":["2021YFE0202800"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"MOST|National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2019YFA0111500"],"award-info":[{"award-number":["2019YFA0111500"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"MOST|National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2017YFE0131600"],"award-info":[{"award-number":["2017YFE0131600"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"name":"The Youth Innovation Promotiona Association Of CAS","award":["2020351"],"award-info":[{"award-number":["2020351"]}]},{"name":"The Guangdong Provincial Significant New Drugs Development","award":["2019B020202003"],"award-info":[{"award-number":["2019B020202003"]}]},{"name":"The Guangdong Provincial Significant New Drugs Development","award":["2020A1515011516"],"award-info":[{"award-number":["2020A1515011516"]}]},{"name":"The Guangdong Provincial Significant New Drugs Development","award":["2019A1515010062"],"award-info":[{"award-number":["2019A1515010062"]}]},{"name":"The Guangzhou Science and Technology Plan Project","award":["201907010042"],"award-info":[{"award-number":["201907010042"]}]},{"name":"The Frontier Research Program of the Guangzhou Regenerative Medicine and Health Guangdong Laboratory","award":["2018GZR110105003"],"award-info":[{"award-number":["2018GZR110105003"]}]},{"name":"Science and Technology Planning Project of Guangdong Province ,China","award":["2020B1212060052"],"award-info":[{"award-number":["2020B1212060052"]}]},{"name":"The Science and Technology Program of Guangzhou, China","award":["202002020083"],"award-info":[{"award-number":["202002020083"]}]},{"name":"The Open project of the State Key Laboratory of Respiratory Disease","award":["SKLRD\u2010OP\u2010202002"],"award-info":[{"award-number":["SKLRD\u2010OP\u2010202002"]}]},{"name":"The University Grants Committee\/Research Grants Council of the Hong Kong","award":["AoE\/M\u2010401\/20"],"award-info":[{"award-number":["AoE\/M\u2010401\/20"]}]},{"name":"Innovation and Technology Fund (ITF) from Hong Kong SAR Government."},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81961128003"],"award-info":[{"award-number":["81961128003"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81972672"],"award-info":[{"award-number":["81972672"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81773301"],"award-info":[{"award-number":["81773301"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81870121"],"award-info":[{"award-number":["81870121"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81873847"],"award-info":[{"award-number":["81873847"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81872069"],"award-info":[{"award-number":["81872069"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32170946"],"award-info":[{"award-number":["32170946"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["EMBO Rep"],"published-print":{"date-parts":[[2022,6,7]]},"DOI":"10.15252\/embr.202154275","type":"journal-article","created":{"date-parts":[[2022,4,19]],"date-time":"2022-04-19T04:55:24Z","timestamp":1650344124000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Transforming primary human hepatocytes into hepatocellular carcinoma with genetically defined factors"],"prefix":"10.1038","volume":"23","author":[{"given":"Zhiwu","family":"Jiang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiping","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linfu","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6910-974X","authenticated-orcid":false,"given":"Haitao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qilan","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiting","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Youguo","family":"Long","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunlin","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaoqi","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yao","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhaoyang","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5621-9755","authenticated-orcid":false,"given":"Zhenfeng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lili","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Likun","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pentao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinwen","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuzhong","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8331-9903","authenticated-orcid":false,"given":"Yinxiong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4530-2400","authenticated-orcid":false,"given":"Peng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,4,19]]},"reference":[{"key":"BFEMBR202154275_CR1","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1038\/s41586-019-1546-z","volume":"573","author":"H Aghajanian","year":"2019","unstructured":"Aghajanian H, Kimura T, Rurik JG, Hancock AS, Leibowitz MS, Li LI, Scholler J, Monslow J, Lo A, Han W et al (2019) Targeting cardiac fibrosis with engineered T cells. Nature 573: 430\u2013433","journal-title":"Nature"},{"key":"BFEMBR202154275_CR2","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1038\/nbt1326","volume":"25","author":"H Azuma","year":"2007","unstructured":"Azuma H, Paulk N, Ranade A, Dorrell C, Al\u2010Dhalimy M, Ellis E, Strom S, Kay MA, Finegold M, Grompe M (2007) Robust expansion of human hepatocytes in Fah\u2010\/\u2010\/Rag2\u2010\/\u2010\/Il2rg\u2010\/\u2010 mice. Nat Biotechnol 25: 903\u2013910","journal-title":"Nat Biotechnol"},{"key":"BFEMBR202154275_CR3","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.cell.2018.02.060","volume":"173","author":"MH Bailey","year":"2018","unstructured":"Bailey MH, Tokheim C, Porta\u2010Pardo E, Sengupta S, Bertrand D, Weerasinghe A, Colaprico A, Wendl MC, Kim J, Reardon B et al (2018) Comprehensive characterization of cancer driver genes and mutations. Cell 173: 371\u2013385 e318","journal-title":"Cell"},{"key":"BFEMBR202154275_CR4","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1126\/science.1139851","volume":"316","author":"F Barabe","year":"2007","unstructured":"Barabe F, Kennedy JA, Hope KJ, Dick JE (2007) Modeling the initiation and progression of human acute leukemia in mice. Science 316: 600\u2013604","journal-title":"Science"},{"key":"BFEMBR202154275_CR5","doi-asserted-by":"crossref","DOI":"10.15252\/embj.2019101654","volume":"38","author":"M Bleijs","year":"2019","unstructured":"Bleijs M, van de Wetering M, Clevers H, Drost J (2019) Xenograft and organoid model systems in cancer research. EMBO J 38: e101654","journal-title":"EMBO J"},{"key":"BFEMBR202154275_CR6","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1038\/nrc2693","volume":"9","author":"R Brosh","year":"2009","unstructured":"Brosh R, Rotter V (2009) When mutants gain new powers: news from the mutant p53 field. Nat Rev Cancer 9: 701\u2013713","journal-title":"Nat Rev Cancer"},{"key":"BFEMBR202154275_CR7","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1038\/nm.4438","volume":"23","author":"L Broutier","year":"2017","unstructured":"Broutier L, Mastrogiovanni G, Verstegen MMA, Francies HE, Gavarr\u00f3 LM, Bradshaw CR, Allen GE, Arnes\u2010Benito R, Sidorova O, Gaspersz MP et al (2017) Human primary liver cancer\u2010derived organoid cultures for disease modeling and drug screening. Nat Med 23: 1424\u20131435","journal-title":"Nat Med"},{"key":"BFEMBR202154275_CR8","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1016\/j.cell.2017.05.046","volume":"169","author":"Cancer Genome Atlas Research Network. Electronic address wbe, Cancer Genome Atlas Research N","year":"2017","unstructured":"Cancer Genome Atlas Research Network. Electronic address wbe, Cancer Genome Atlas Research N (2017) Comprehensive and integrative genomic characterization of hepatocellular carcinoma. Cell 169: 1327\u20131341 e1323","journal-title":"Cell"},{"key":"BFEMBR202154275_CR9","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1111\/his.12342","volume":"64","author":"AW Chan","year":"2014","unstructured":"Chan AW, Tong JH, Chan SL, Lai PB, To KF (2014) Expression of stemness markers (CD133 and EpCAM) in prognostication of hepatocellular carcinoma. Histopathology 64: 935\u2013950","journal-title":"Histopathology"},{"key":"BFEMBR202154275_CR10","doi-asserted-by":"crossref","first-page":"1846926","DOI":"10.1080\/2162402X.2020.1846926","volume":"9","author":"H Dai","year":"2020","unstructured":"Dai H, Tong C, Shi D, Chen M, Guo Y, Chen D, Han X, Wang H, Wang Y, Shen P (2020) Efficacy and biomarker analysis of CD133\u2010directed CAR T cells in advanced hepatocellular carcinoma: a single\u2010arm, open\u2010label, phase II trial. OncoImmunology 9: 1846926","journal-title":"OncoImmunology"},{"key":"BFEMBR202154275_CR11","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1038\/nature14415","volume":"521","author":"J Drost","year":"2015","unstructured":"Drost J, van Jaarsveld RH, Ponsioen B, Zimberlin C, van Boxtel R, Buijs A, Sachs N, Overmeer RM, Offerhaus GJ, Begthel H et al (2015) Sequential cancer mutations in cultured human intestinal stem cells. Nature 521: 43\u201347","journal-title":"Nature"},{"key":"BFEMBR202154275_CR12","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.ccell.2020.05.010","volume":"38","author":"LF Escobar\u2010Hoyos","year":"2020","unstructured":"Escobar\u2010Hoyos LF, Penson A, Kannan R, Cho H, Pan C\u2010H, Singh RK, Apken LH, Hobbs GA, Luo R, Lecomte N et al (2020) Altered RNA splicing by mutant p53 activates oncogenic RAS signaling in pancreatic cancer. Cancer Cell 38: 198\u2013211.e8","journal-title":"Cancer Cell"},{"key":"BFEMBR202154275_CR13","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/j.cell.2019.08.052","volume":"179","author":"Q Gao","year":"2019","unstructured":"Gao Q, Zhu H, Dong L, Shi W, Chen R, Song Z, Huang C, Li J, Dong X, Zhou Y et al (2019) Integrated proteogenomic characterization of HBV\u2010related hepatocellular carcinoma. Cell 179: 561\u2013577 e522","journal-title":"Cell"},{"key":"BFEMBR202154275_CR14","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1136\/gutjnl-2012-304351","volume":"63","author":"O Govaere","year":"2014","unstructured":"Govaere O, Komuta M, Berkers J, Spee B, Janssen C, de Luca F, Katoonizadeh A, Wouters J, van Kempen LC, Durnez A et al (2014) Keratin 19: a key role player in the invasion of human hepatocellular carcinomas. Gut 63: 674\u2013685","journal-title":"Gut"},{"key":"BFEMBR202154275_CR15","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1038\/22780","volume":"400","author":"WC Hahn","year":"1999","unstructured":"Hahn WC, Counter CM, Lundberg AS, Beijersbergen RL, Brooks MW, Weinberg RA (1999) Creation of human tumour cells with defined genetic elements. Nature 400: 464\u2013468","journal-title":"Nature"},{"key":"BFEMBR202154275_CR16","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1002\/1097-0142(19940101)73:1<42::AID-CNCR2820730109>3.0.CO;2-D","volume":"73","author":"HC Hsu","year":"1994","unstructured":"Hsu HC, Peng SY, Lai PL, Sheu JC, Chen DS, Lin LI, Slagle BL, Butel JS (1994) Allelotype and loss of heterozygosity of p53 in primary and recurrent hepatocellular carcinomas. A study of 150 patients. Cancer 73: 42\u201347","journal-title":"Cancer"},{"key":"BFEMBR202154275_CR17","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1038\/350427a0","volume":"350","author":"IC Hsu","year":"1991","unstructured":"Hsu IC, Metcalf RA, Sun T, Welsh JA, Wang NJ, Harris CC (1991) Mutational hotspot in the p53 gene in human hepatocellular carcinomas. Nature 350: 427\u2013428","journal-title":"Nature"},{"key":"BFEMBR202154275_CR18","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.stem.2014.01.003","volume":"14","author":"P Huang","year":"2014","unstructured":"Huang P, Zhang L, Gao Y, He Z, Yao D, Wu Z, Cen J, Chen X, Liu C, Hu Y et al (2014) Direct reprogramming of human fibroblasts to functional and expandable hepatocytes. Cell Stem Cell 14: 370\u2013384","journal-title":"Cell Stem Cell"},{"key":"BFEMBR202154275_CR19","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1158\/1541-7786.MCR-15-0203","volume":"13","author":"JC Hunter","year":"2015","unstructured":"Hunter JC, Manandhar A, Carrasco MA, Gurbani D, Gondi S, Westover KD (2015) Biochemical and structural analysis of common cancer\u2010associated KRAS mutations. Mol Cancer Res 13: 1325\u20131335","journal-title":"Mol Cancer Res"},{"key":"BFEMBR202154275_CR20","doi-asserted-by":"crossref","first-page":"2166","DOI":"10.1038\/sj.onc.1210279","volume":"26","author":"SP Hussain","year":"2007","unstructured":"Hussain SP, Schwank J, Staib F, Wang XW, Harris CC (2007) TP53 mutations and hepatocellular carcinoma: insights into the etiology and pathogenesis of liver cancer. Oncogene 26: 2166\u20132176","journal-title":"Oncogene"},{"key":"BFEMBR202154275_CR21","doi-asserted-by":"crossref","first-page":"690","DOI":"10.3389\/fimmu.2016.00214","volume":"7","author":"Z Jiang","year":"2016","unstructured":"Jiang Z, Jiang X, Chen S, Lai Y, Wei X, Li B, Lin S, Wang S, Wu Q, Liang Q et al (2016) Anti\u2010GPC3\u2010CAR T cells suppress the growth of tumor cells in patient\u2010derived xenografts of hepatocellular carcinoma. Front Immunol 7: 690","journal-title":"Front Immunol"},{"key":"BFEMBR202154275_CR22","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1126\/science.2595371","volume":"246","author":"S Kamel\u2010Reid","year":"1989","unstructured":"Kamel\u2010Reid S, Letarte M, Sirard C, Doedens M, Grunberger T, Fulop G, Freedman MH, Phillips RA, Dick JE (1989) A model of human acute lymphoblastic leukemia in immune\u2010deficient SCID mice. Science 246: 1597\u20131600","journal-title":"Science"},{"key":"BFEMBR202154275_CR23","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1038\/nature10599","volume":"479","author":"T\u2010W Kang","year":"2011","unstructured":"Kang T\u2010W, Yevsa T, Woller N, Hoenicke L, Wuestefeld T, Dauch D, Hohmeyer A, Gereke M, Rudalska R, Potapova A et al (2011) Senescence surveillance of pre\u2010malignant hepatocytes limits liver cancer development. Nature 479: 547\u2013551","journal-title":"Nature"},{"key":"BFEMBR202154275_CR24","doi-asserted-by":"crossref","unstructured":"Kasprzak A, Adamek A (2019) Mucins: the old, the new and the promising factors in hepatobiliary carcinogenesis. Int J Mol Sci 20","DOI":"10.3390\/ijms20061288"},{"key":"BFEMBR202154275_CR25","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1126\/science.256.5058.827","volume":"256","author":"SE Kern","year":"1992","unstructured":"Kern SE, Pietenpol JA, Thiagalingam S, Seymour A, Kinzler KW, Vogelstein B (1992) Oncogenic forms of p53 inhibit p53\u2010regulated gene expression. Science 256: 827\u2013830","journal-title":"Science"},{"key":"BFEMBR202154275_CR26","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1096\/fj.00-0487fje","volume":"15","author":"R Klocke","year":"2001","unstructured":"Klocke R, Bartels T, Jennings G, Brand K, Halter R, Strauss M, Paul D (2001) Lack of p53 accelerates hepatocarcinogenesis in transgenic mice constitutively overexpressing c\u2010myc in the liver. FASEB J 15: 1404\u20131406","journal-title":"FASEB J"},{"key":"BFEMBR202154275_CR27","doi-asserted-by":"crossref","first-page":"1858","DOI":"10.1002\/hep.510290636","volume":"29","author":"N Kusano","year":"1999","unstructured":"Kusano N, Shiraishi K, Kubo K, Oga A, Okita K, Sasaki K (1999) Genetic aberrations detected by comparative genomic hybridization in hepatocellular carcinomas: their relationship to clinicopathological features. Hepatology 29: 1858\u20131862","journal-title":"Hepatology"},{"key":"BFEMBR202154275_CR28","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1186\/s13045-017-0470-7","volume":"10","author":"Y Lai","year":"2017","unstructured":"Lai Y, Wei X, Lin S, Qin L, Cheng L, Li P (2017) Current status and perspectives of patient\u2010derived xenograft models in cancer research. J Hematol Oncol 10: 106","journal-title":"J Hematol Oncol"},{"key":"BFEMBR202154275_CR29","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1038\/leu.2017.249","volume":"32","author":"Y Lai","year":"2018","unstructured":"Lai Y, Weng J, Wei X, Qin L, Lai P, Zhao R, Jiang Z, Li B, Lin S, Wang S et al (2018) Toll\u2010like receptor 2 costimulation potentiates the antitumor efficacy of CAR T Cells. Leukemia 32: 801\u2013808","journal-title":"Leukemia"},{"key":"BFEMBR202154275_CR30","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1016\/j.molcel.2017.11.006","volume":"68","author":"P Liao","year":"2017","unstructured":"Liao P, Zeng SX, Zhou X, Chen T, Zhou F, Cao B, Jung JH, Del Sal G, Luo S, Lu H (2017) Mutant p53 gains its Function via c\u2010Myc activation upon CDK4 phosphorylation at serine 249 and consequent PIN1 binding. Mol Cell 68: 1134\u20131146.e6","journal-title":"Mol Cell"},{"key":"BFEMBR202154275_CR31","volume":"39","author":"Z Lin","year":"2020","unstructured":"Lin Z, Niu Y, Wan A, Chen D, Liang H, Chen X, Sun L, Zhan S, Chen L, Cheng C et al (2020) RNA m(6) A methylation regulates sorafenib resistance in liver cancer through FOXO3\u2010mediated autophagy. EMBO J 39: e103181","journal-title":"EMBO J"},{"key":"BFEMBR202154275_CR32","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1158\/1078-0432.CCR-16-1203","volume":"23","author":"H Liu","year":"2017","unstructured":"Liu H, Xu Y, Xiang J, Long LI, Green S, Yang Z, Zimdahl B, Lu J, Cheng N, Horan LH et al (2017) Targeting alpha\u2010fetoprotein (AFP)\u2010MHC complex with CAR T\u2010cell therapy for liver cancer. Clin Cancer Res 23: 478\u2013488","journal-title":"Clin Cancer Res"},{"key":"BFEMBR202154275_CR33","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1016\/S0140-6736(03)14964-1","volume":"362","author":"JM Llovet","year":"2003","unstructured":"Llovet JM, Burroughs A, Bruix J (2003) Hepatocellular carcinoma. Lancet 362: 1907\u20131917","journal-title":"Lancet"},{"key":"BFEMBR202154275_CR34","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1038\/s41571-018-0073-4","volume":"15","author":"JM Llovet","year":"2018","unstructured":"Llovet JM, Montal R, Sia D, Finn RS (2018) Molecular therapies and precision medicine for hepatocellular carcinoma. Nat Rev Clin Oncol 15: 599\u2013616","journal-title":"Nat Rev Clin Oncol"},{"key":"BFEMBR202154275_CR35","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1038\/nrclinonc.2015.103","volume":"12","author":"JM Llovet","year":"2015","unstructured":"Llovet JM, Villanueva A, Lachenmayer A, Finn RS (2015) Advances in targeted therapies for hepatocellular carcinoma in the genomic era. Nat Rev Clin Oncol 12: 408\u2013424","journal-title":"Nat Rev Clin Oncol"},{"key":"BFEMBR202154275_CR36","doi-asserted-by":"crossref","DOI":"10.15252\/embr.202153085","volume":"22","author":"S Mehta","year":"2021","unstructured":"Mehta S, Campbell H, Drummond CJ, Li K, Murray K, Slatter T, Bourdon JC, Braithwaite AW (2021) Adaptive homeostasis and the p53 isoform network. EMBO Rep 22: e53085","journal-title":"EMBO Rep"},{"key":"BFEMBR202154275_CR37","doi-asserted-by":"crossref","first-page":"181006","DOI":"10.1098\/rsos.181006","volume":"5","author":"O Menyhart","year":"2018","unstructured":"Menyhart O, Nagy A, Gyorffy B (2018) Determining consistent prognostic biomarkers of overall survival and vascular invasion in hepatocellular carcinoma. R Soc Open Sci 5: 181006","journal-title":"R Soc Open Sci"},{"key":"BFEMBR202154275_CR38","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1016\/j.stem.2020.04.003","volume":"26","author":"BE Michels","year":"2020","unstructured":"Michels BE, Mosa MH, Streibl BI, Zhan T, Menche C, Abou\u2010El\u2010Ardat K, Darvishi T, Cz\u0142onka E, Wagner S, Winter J et al (2020) Pooled in vitro and in vivo CRISPR\u2010Cas9 screening identifies tumor suppressors in human colon organoids. Cell Stem Cell 26: 782\u2013792.e787","journal-title":"Cell Stem Cell"},{"key":"BFEMBR202154275_CR39","doi-asserted-by":"crossref","first-page":"4245","DOI":"10.1073\/pnas.1208949110","volume":"110","author":"Q Mo","year":"2013","unstructured":"Mo Q, Wang S, Seshan VE, Olshen AB, Schultz N, Sander C, Powers RS, Ladanyi M, Shen R (2013) Pattern discovery and cancer gene identification in integrated cancer genomic data. Proc Natl Acad Sci USA 110: 4245\u20134250","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFEMBR202154275_CR40","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1158\/0008-5472.CAN-11-3596","volume":"72","author":"MR O'Dell","year":"2012","unstructured":"O'Dell MR, Huang JL, Whitney\u2010Miller CL, Deshpande V, Rothberg P, Grose V, Rossi RM, Zhu AX, Land H, Bardeesy N et al (2012) Kras(G12D) and p53 mutation cause primary intrahepatic cholangiocarcinoma. Cancer Res 72: 1557\u20131567","journal-title":"Cancer Res"},{"key":"BFEMBR202154275_CR41","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1038\/ng2047","volume":"39","author":"DT Odom","year":"2007","unstructured":"Odom DT, Dowell RD, Jacobsen ES, Gordon W, Danford TW, MacIsaac KD, Rolfe PA, Conboy CM, Gifford DK, Fraenkel E (2007) Tissue\u2010specific transcriptional regulation has diverged significantly between human and mouse. Nat Genet 39: 730\u2013732","journal-title":"Nat Genet"},{"key":"BFEMBR202154275_CR42","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1053\/j.gastro.2006.08.014","volume":"131","author":"TC Poon","year":"2006","unstructured":"Poon TC, Wong N, Lai PB, Rattray M, Johnson PJ, Sung JJ (2006) A tumor progression model for hepatocellular carcinoma: bioinformatic analysis of genomic data. Gastroenterology 131: 1262\u20131270","journal-title":"Gastroenterology"},{"key":"BFEMBR202154275_CR43","doi-asserted-by":"crossref","first-page":"5730","DOI":"10.3748\/wjg.14.5730","volume":"14","author":"MS Rao","year":"2008","unstructured":"Rao MS, Khan AA, Parveen N, Habeeb MA, Habibullah CM, Pande G (2008) Characterization of hepatic progenitors from human fetal liver during second trimester. World J Gastroenterol 14: 5730\u20135737","journal-title":"World J Gastroenterol"},{"key":"BFEMBR202154275_CR44","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1126\/science.aas9090","volume":"362","author":"M Ruscetti","year":"2018","unstructured":"Ruscetti M, Leibold J, Bott MJ, Fennell M, Kulick A, Salgado NR, Chen C\u2010C, Ho Y\u2010J, Sanchez\u2010Rivera FJ, Feucht J et al (2018) NK cell\u2010mediated cytotoxicity contributes to tumor control by a cytostatic drug combination. Science 362: 1416\u20131422","journal-title":"Science"},{"key":"BFEMBR202154275_CR45","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/j.cell.2020.03.008","volume":"181","author":"M Ruscetti","year":"2020","unstructured":"Ruscetti M, Morris JP, Mezzadra R, Russell J, Leibold J, Romesser PB, Simon J, Kulick A, Ho Y\u2010J, Fennell M et al (2020) Senescence\u2010induced vascular remodeling creates therapeutic vulnerabilities in pancreas cancer. Cell 181: 424\u2013441.e21","journal-title":"Cell"},{"key":"BFEMBR202154275_CR46","doi-asserted-by":"crossref","DOI":"10.15252\/embr.202052061","volume":"22","author":"R Sales\u2010Gil","year":"2021","unstructured":"Sales\u2010Gil R, Kommer DC, de Castro IJ, Amin HA, Vinciotti V, Sisu C, Vagnarelli P (2021) Non\u2010redundant functions of H2A.Z.1 and H2A.Z.2 in chromosome segregation and cell cycle progression. EMBO Rep 22: e52061","journal-title":"EMBO Rep"},{"key":"BFEMBR202154275_CR47","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1002\/hep.22033","volume":"47","author":"C Schlaeger","year":"2008","unstructured":"Schlaeger C, Longerich T, Schiller C, Bewerunge P, Mehrabi A, Toedt G, Kleeff J, Ehemann V, Eils R, Lichter P et al (2008) Etiology\u2010dependent molecular mechanisms in human hepatocarcinogenesis. Hepatology 47: 511\u2013520","journal-title":"Hepatology"},{"key":"BFEMBR202154275_CR48","doi-asserted-by":"crossref","DOI":"10.15252\/embj.2018100928","volume":"38","author":"TE Schnalzger","year":"2019","unstructured":"Schnalzger TE, de Groot MH, Zhang C, Mosa MH, Michels BE, R\u00f6der J, Darvishi T, Wels WS, Farin HF (2019) 3D model for CAR\u2010mediated cytotoxicity using patient\u2010derived colorectal cancer organoids. EMBO J 38: e100928","journal-title":"EMBO J"},{"key":"BFEMBR202154275_CR49","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1038\/ng.3252","volume":"47","author":"K Schulze","year":"2015","unstructured":"Schulze K, Imbeaud S, Letouz\u00e9 E, Alexandrov LB, Calderaro J, Rebouissou S, Couchy G, Meiller C, Shinde J, Soysouvanh F et al (2015) Exome sequencing of hepatocellular carcinomas identifies new mutational signatures and potential therapeutic targets. Nat Genet 47: 505\u2013511","journal-title":"Nat Genet"},{"key":"BFEMBR202154275_CR50","doi-asserted-by":"crossref","first-page":"3979","DOI":"10.1158\/1078-0432.CCR-19-3259","volume":"26","author":"D Shi","year":"2020","unstructured":"Shi D, Shi Y, Kaseb AO, Qi X, Zhang Y, Chi J, Lu Q, Gao H, Jiang H, Wang H et al (2020) Chimeric antigen receptor\u2010glypican\u20103 T\u2010cell therapy for advanced hepatocellular carcinoma: results of phase I trials. Clin Cancer Res 26: 3979\u20133989","journal-title":"Clin Cancer Res"},{"key":"BFEMBR202154275_CR51","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1038\/nri2017","volume":"7","author":"LD Shultz","year":"2007","unstructured":"Shultz LD, Ishikawa F, Greiner DL (2007) Humanized mice in translational biomedical research. Nat Rev Immunol 7: 118\u2013130","journal-title":"Nat Rev Immunol"},{"key":"BFEMBR202154275_CR52","doi-asserted-by":"crossref","DOI":"10.15252\/embr.202050893","volume":"21","author":"VC Sladky","year":"2020","unstructured":"Sladky VC, Knapp K, Szabo TG, Braun VZ, Bongiovanni L, Bos H, Spierings DCJ, Westendorp B, Curinha A, Stojakovic T et al (2020) PIDDosome\u2010induced p53\u2010dependent ploidy restriction facilitates hepatocarcinogenesis. EMBO Rep 21: e50893","journal-title":"EMBO Rep"},{"key":"BFEMBR202154275_CR53","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1038\/s41556-019-0359-5","volume":"21","author":"L Sun","year":"2019","unstructured":"Sun L, Wang Y, Cen J, Ma X, Cui L, Qiu Z, Zhang Z, Li H, Yang R\u2010Z, Wang C et al (2019) Modelling liver cancer initiation with organoids derived from directly reprogrammed human hepatocytes. Nat Cell Biol 21: 1015\u20131026","journal-title":"Nat Cell Biol"},{"key":"BFEMBR202154275_CR54","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/S0002-9440(10)63352-4","volume":"165","author":"C Tateno","year":"2004","unstructured":"Tateno C, Yoshizane Y, Saito N, Kataoka M, Utoh R, Yamasaki C, Tachibana A, Soeno Y, Asahina K, Hino H et al (2004) Near completely humanized liver in mice shows human\u2010type metabolic responses to drugs. Am J Pathol 165: 901\u2013912","journal-title":"Am J Pathol"},{"key":"BFEMBR202154275_CR55","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1038\/ng.3126","volume":"46","author":"Y Totoki","year":"2014","unstructured":"Totoki Y, Tatsuno K, Covington KR, Ueda H, Creighton CJ, Kato M, Tsuji S, Donehower LA, Slagle BL, Nakamura H et al (2014) Trans\u2010ancestry mutational landscape of hepatocellular carcinoma genomes. Nat Genet 46: 1267\u20131273","journal-title":"Nat Genet"},{"key":"BFEMBR202154275_CR56","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/1476-4598-8-29","volume":"8","author":"P Trerotoli","year":"2009","unstructured":"Trerotoli P, Fransvea E, Angelotti U, Antonaci G, Lupo L, Mazzocca A, Mangia A, Antonaci S, Giannelli G (2009) Tissue expression of Squamous Cellular Carcinoma Antigen (SCCA) is inversely correlated to tumor size in HCC. Mol Cancer 8: 29","journal-title":"Mol Cancer"},{"key":"BFEMBR202154275_CR57","doi-asserted-by":"crossref","first-page":"4810","DOI":"10.1038\/s41467-020-18444-2","volume":"11","author":"H\u2010C Tseng","year":"2020","unstructured":"Tseng H\u2010C, Xiong W, Badeti S, Yang Y, Ma M, Liu T, Ramos CA, Dotti G, Fritzky L, Jiang J\u2010G et al (2020) Efficacy of anti\u2010CD147 chimeric antigen receptors targeting hepatocellular carcinoma. Nat Commun 11: 4810","journal-title":"Nat Commun"},{"key":"BFEMBR202154275_CR58","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1038\/s41586-019-1607-3","volume":"574","author":"C Wang","year":"2019","unstructured":"Wang C, Vegna S, Jin H, Benedict B, Lieftink C, Ramirez C, de Oliveira RL, Morris B, Gadiot J, Wang W et al (2019) Inducing and exploiting vulnerabilities for the treatment of liver cancer. Nature 574: 268\u2013272","journal-title":"Nature"},{"key":"BFEMBR202154275_CR59","volume":"6","author":"X Wei","year":"2017","unstructured":"Wei X, Lai Y, Li J, Qin LE, Xu Y, Zhao R, Li B, Lin S, Wang S, Wu Q et al (2017) PSCA and MUC1 in non\u2010small\u2010cell lung cancer as targets of chimeric antigen receptor T cells. Oncoimmunology 6: e1284722","journal-title":"Oncoimmunology"},{"key":"BFEMBR202154275_CR60","volume":"11","author":"D Xu","year":"2014","unstructured":"Xu D, Nishimura T, Nishimura S, Zhang H, Zheng M, Guo YY, Masek M, Michie SA, Glenn J, Peltz G (2014) Fialuridine induces acute liver failure in chimeric TK\u2010NOG mice: a model for detecting hepatic drug toxicity prior to human testing. PLoS Med 11: e1001628","journal-title":"PLoS Med"},{"key":"BFEMBR202154275_CR61","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/s13045-015-0156-y","volume":"8","author":"W Ye","year":"2015","unstructured":"Ye W, Jiang Z, Li G\u2010X, Xiao Y, Lin S, Lai Y, Wang S, Li B, Jia B, Li Y et al (2015) Quantitative evaluation of the immunodeficiency of a mouse strain by tumor engraftments. J Hematol Oncol 8: 59","journal-title":"J Hematol Oncol"},{"key":"BFEMBR202154275_CR62","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1016\/j.stem.2018.10.018","volume":"23","author":"K Zhang","year":"2018","unstructured":"Zhang K, Zhang L, Liu W, Ma X, Cen J, Sun Z, Wang C, Feng S, Zhang Z, Yue L et al (2018) In vitro expansion of primary human hepatocytes with efficient liver repopulation capacity. Cell Stem Cell 23: 806\u2013819 e804","journal-title":"Cell Stem Cell"},{"key":"BFEMBR202154275_CR63","volume":"21","author":"K Zhao","year":"2020","unstructured":"Zhao K, Wang D, Zhao X, Wang C, Gao Y, Liu K, Wang F, Wu X, Wang X, Sun L et al (2020) WDR63 inhibits Arp2\/3\u2010dependent actin polymerization and mediates the function of p53 in suppressing metastasis. EMBO Rep 21: e49269","journal-title":"EMBO Rep"},{"key":"BFEMBR202154275_CR64","doi-asserted-by":"crossref","DOI":"10.15252\/embj.201899599","volume":"38","author":"Y Zhao","year":"2019","unstructured":"Zhao Y, Ding L, Wang D, Ye Z, He Y, Ma L, Zhu R, Pan Y, Wu Q, Pang K et al (2019) EZH2 cooperates with gain\u2010of\u2010function p53 mutants to promote cancer growth and metastasis. EMBO J 38: e99599","journal-title":"EMBO J"},{"key":"BFEMBR202154275_CR65","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.3389\/fimmu.2019.01149","volume":"10","author":"R Zhou","year":"2019","unstructured":"Zhou R, Yazdanifar M, Roy LD, Whilding LM, Gavrill A, Maher J, Mukherjee P (2019) CAR T cells targeting the tumor MUC1 glycoprotein reduce triple\u2010negative breast cancer growth. Front Immunol 10: 1149","journal-title":"Front Immunol"},{"key":"BFEMBR202154275_CR66","doi-asserted-by":"crossref","first-page":"1975","DOI":"10.3748\/wjg.v10.i13.1975","volume":"10","author":"GN Zhu","year":"2004","unstructured":"Zhu GN, Zuo L, Zhou Q, Zhang SM, Zhu HQ, Gui SY, Wang Y (2004) Loss of heterozygosity on chromosome 10q22\u201010q23 and 22q11.2\u201022q12.1 and p53 gene in primary hepatocellular carcinoma. World J Gastroenterol 10: 1975\u20131978","journal-title":"World J Gastroenterol"},{"key":"BFEMBR202154275_CR67","doi-asserted-by":"crossref","first-page":"3278","DOI":"10.7150\/jca.25775","volume":"9","author":"B Zou","year":"2018","unstructured":"Zou B, Liu X, Zhang B, Gong Y, Cai C, Li P, Chen J, Xing S, Chen J, Peng S et al (2018) The expression of FAP in hepatocellular carcinoma cells is induced by hypoxia and correlates with poor clinical outcomes. J Cancer 9: 3278\u20133286","journal-title":"J Cancer"}],"container-title":["The EMBO Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.15252\/embr.202154275.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.15252\/embr.202154275","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.15252\/embr.202154275\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.embopress.org\/doi\/pdf\/10.15252\/embr.202154275","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.15252\/embr.202154275.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T14:00:43Z","timestamp":1779112843000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.15252\/embr.202154275"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,19]]},"references-count":67,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2022,6,7]]}},"alternative-id":["BFEMBR202154275"],"URL":"https:\/\/doi.org\/10.15252\/embr.202154275","relation":{},"ISSN":["1469-221X","1469-3178"],"issn-type":[{"value":"1469-221X","type":"print"},{"value":"1469-3178","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,4,19]]},"assertion":[{"value":"4 November 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 April 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 April 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 April 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosure and competing interests statement"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}],"article-number":"EMBR202154275"}}